HealthEquity, Inc.(HQY)
$105.39—Earnings tomorrow
HealthEquity, Inc.(HQY)
NASDAQ
$105.39—Earnings tomorrow
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $1.42B | $1.52B | $1.63B |
| Low | $1.41B | $1.48B | $1.59B |
| High | $1.44B | $1.55B | $1.65B |
| EBITDA Avg | $804M | $864M | $924M |
| Low | $799M | $841M | $906M |
| High | $818M | $881M | $939M |
| EBIT Avg | $716M | $769M | $823M |
| Low | $711M | $749M | $807M |
| High | $729M | $784M | $836M |
| Net Income Avg | $413M | $475M | $527M |
| Low | $409M | $457M | $504M |
| High | $417M | $492M | $550M |
| EPS Avg | $4.72 | $5.45 | $6.01 |
| Low | $4.68 | $5.22 | $5.76 |
| High | $4.77 | $5.63 | $6.29 |
| Analysts (Rev / EPS) | 11 / 10 | 11 / 10 | 4 / 3 |
| Metric | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 |
|---|---|---|---|---|---|---|
| Revenue Avg | $347M | $365M | $384M | $376M | $373M | $390M |
| Low | $345M | $362M | $381M | $373M | $370M | $388M |
| High | $348M | $367M | $386M | $378M | $375M | $393M |
| EBITDA Avg | $197M | $207M | $218M | $214M | $212M | $222M |
| Low | $196M | $206M | $217M | $212M | $210M | $220M |
| High | $198M | $209M | $219M | $215M | $213M | $223M |
| EBIT Avg | $175M | $185M | $194M | $190M | $189M | $198M |
| Low | $175M | $183M | $193M | $189M | $187M | $196M |
| High | $176M | $186M | $195M | $191M | $190M | $199M |
| Net Income Avg | $98M | $96M | $118M | $116M | $113M | $113M |
| Low | $97M | $95M | $117M | $115M | $112M | $112M |
| High | $100M | $97M | $119M | $117M | $114M | $114M |
| EPS Avg | $1.15 | $1.13 | $1.39 | $1.37 | $1.33 | $1.33 |
| Low | $1.14 | $1.12 | $1.38 | $1.36 | $1.32 | $1.31 |
| High | $1.17 | $1.14 | $1.40 | $1.38 | $1.34 | $1.34 |
| Analysts (Rev / EPS) | 9 / 9 | 5 / 4 | 8 / 7 | 4 / 3 | 5 / 4 | 5 / 6 |